Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr–Abl positive cells

Brian Druker(Oregon Health & Science University), Shu Tamura(Oregon Health & Science University), Elisabeth Buchdunger(Novartis (Switzerland)), Sayuri Ohno(Oregon Health & Science University), Gerald M. Segal(Oregon Health & Science University), Shane Fanning(Oregon Health & Science University), J. Zimmermann(Novartis (Switzerland)), Nicholas Lydon(Novartis (Switzerland))
Nature Medicine
May 1, 1996
10.1038/nm0596-561
Cited by 3,656

Abstract

Related Papers

A New Consistent Chromosomal Abnormality in Chronic Myelogenous Leukaemia identified by Quinacrine Fluorescence and Giemsa Staining
Janet D. Rowley|Nature|1973|4.3k
A minute chromosome in human chronic granulocytic leukemia
Peter C. Nowell̀|Medical Entomology and Zoology|1960|2.3k
Translocation of c-abl oncogene correlates with the presence of a Philadelphia chromosome in chronic myelocytic leukaemia
Claus R. Bartram, Annelies de Klein, Anne Hagemeijer et al.|Nature|1983|762
Interferon Alfa-2a as Compared with Conventional Chemotherapy for the Treatment of Chronic Myeloid Leukemia
The Italian Cooperative Study Group on Chronic Myeloid Leukemia|New England Journal of Medicine|1994|591
cdc2 is a component of the M phase-specific histone H1 kinase: Evidence for identity with MPF
Dominique Arion, Laurent Meijer, Leonardo Brizuela et al.|Cell|1988|535